CDH1 and benign prostatic hyperplasia: identified that elevated O-GlcNAcylation levels induces malignant transformation of nontumorigenic benign prostatic hyperplasia (BPH) cells, enhancing migratory and invasive ability through inhibiting the formation of the E-cadherin/catenin/cytoskeleton complex (66).